Seven Bridges Overview
- Founded
- 2009

- Status
- Private
- Employees
- 294

- Latest Deal Type
- Series C
- Latest Deal Amount
- $15M

- Investors
- 4
Seven Bridges General Information
Description
Developer of a biomedical data analysis platform designed to accelerate scientific discovery. The company's platform delivers end-to-end bioinformatic data analytics including access to datasets, analytic workflows and algorithms, cloud-computing infrastructure and scientific support that speeds the path from raw experimental data to new treatments and diagnostics, enabling companies to accelerate scientific discovery with secure and collaborative genomic and healthcare data analytics.
Contact Information
- Schrafft's City Center, 529 Main Street
- Suite 6610, Charlestown
- Boston, MA 02129
- United States
Seven Bridges Timeline
Seven Bridges Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
9. Later Stage VC (Series C) | 27-Apr-2021 | $15M | 00000 | 00000 | Completed | Generating Revenue |
8. Debt - PPP | 01-May-2020 | 00000 | 0000 | Completed | Generating Revenue | |
7. Later Stage VC (Series B) | 01-Apr-2018 | 0000 | 0000 | 0000 | Completed | Generating Revenue |
6. Secondary Transaction - Private | 0000 | Completed | Generating Revenue | |||
5. Grant | 07-Nov-2017 | 0000 | Completed | Generating Revenue | ||
4. Later Stage VC (Series A) | 16-Feb-2016 | 0000 | 0000 | 00000 | Completed | Generating Revenue |
3. Grant | 11-Mar-2015 | 00.000 | 000 | Completed | Generating Revenue | |
2. Seed Round | 01-Jan-2014 | $3M | $3M | 0000 | Completed | Startup |
1. Debt - General | Completed | Startup |
Seven Bridges Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series C | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 | |
Series B | 000,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 | |
Series A1 | 497,354 | $0.000010 | $129.8 | $129.8 | 1x | $3.22 | 7.26% | |
Series A | 6,690 | $0.000010 | $100 | $100 | 1x | $100 | 0% |
Seven Bridges Comparisons
Industry
0000000
00000000
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialSeven Bridges Competitors (3)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Genuity Science | Formerly VC-backed | Boston, MA | 000 | 00000 | 000000&0 | 00000 |
00000000 | Venture Capital-Backed | Mountain View, CA | 000 | 00000 | 00000000000 | 00000 |
00000 | Formerly PE-Backed | Durham, NC | 00000 | 00000 | 000000000 | 00000 |
Seven Bridges Patents
Seven Bridges Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20190267110-A1 | System and method for sequence identification in reassembly variant calling | Pending | 14-Feb-2018 | 000000000 | |
US-20190214110-A1 | Detection of insufficient homology regions in a reference sequence | Pending | 07-Dec-2017 | 000000000 | |
US-10678613-B2 | System and method for dynamic control of workflow execution | Active | 31-Oct-2017 | 000000000 | 0 |
US-20190129769-A1 | System and method for dynamic control of workflow execution | Granted | 31-Oct-2017 | 000000000 | |
US-20200326999-A1 | System and method for dynamic control of workflow execution | Pending | 31-Oct-2017 | G06F9/543 |
Seven Bridges Executive Team (29)
Seven Bridges Board Members (6)
Name | Representing | Role | Since |
---|---|---|---|
Evren Ozturk | Seven Bridges | Board Member | 000 0000 |
Heng Li | Seven Bridges | Scientific Advisory Board Member | 000 0000 |
James Knight | Seven Bridges | Scientific Advisory Board Member | 000 0000 |
William Moss | Seven Bridges | Chief Executive Officer & Board Member | 000 0000 |
Seven Bridges Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialSeven Bridges Investors (4)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
National Institutes of Health | Government | 000 0000 | 000000 0 | ||
Kryssen Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
Genomics England | Other | 000 0000 | 000000 0 | ||
U.K. Department of Health & Social Care | Government | 000 0000 | 000000 0 |
Seven Bridges Investments (1)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
0000000 00000 | 04-Apr-2017 | 000000000 | Biotechnology | 000000 00 |
Seven Bridges Exits (1)
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
0000000 0000000000 | 04-Apr-2017 | 000000000 | Completed |
|